These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 70094)

  • 1. [Increase of the concentration of effector T-lymphocytes specific to antigens H2. 1. Elution of T-lymphocytes from the allogeneic target cells].
    Brondz BD; Egorova CG
    Tsitologiia; 1976 Nov; 18(11):1387-92. PubMed ID: 70094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of cytotoxic t-lymphocytes eluted from allogenic target cells].
    Egorov SG; Brondz BD
    Biull Eksp Biol Med; 1977 Jan; 83(1):50-3. PubMed ID: 322755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors.
    Bevan MJ
    J Immunol; 1975 Jan; 114(1 Pt 2):316-9. PubMed ID: 123256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K; Chang AE; Shu SY
    Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of effector T lymphocytes specific to H-2 antigens by elution from allogeneic target cells and characterization of the eluted lymphocyte population.
    Brondz BD; Egorova SG; Kotomina IF
    Eur J Immunol; 1975 Nov; 5(11):773-41. PubMed ID: 829900
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
    Kaneko Y; Natsuume-Sakai S; Migita S
    J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxic activity of mouse T lymphocytes against allogeneic cytotoxic T cells.
    Wagner H; Trostmann H; Pfizenmaier K; Röllinghoff M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Aug; 150(1):81-9. PubMed ID: 127466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of soluble H-2 antigens on the cytotoxic effect and adsorption of immune lymphocytes].
    Kotomina IF; Pletneva TP
    Biull Eksp Biol Med; 1977 Sep; 84(9):333-6. PubMed ID: 334284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane phenotype of the rat cytotoxic T lymphocyte.
    Gilman SC; Rosenberg JS; Feldman JD
    J Immunol; 1982 Sep; 129(3):1012-6. PubMed ID: 6980913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence for receptors of the specific T-suppressor cells immune to the H-2 antigens, and enrichment of these cells by fractionation on target cell monolayer].
    Brondz BD; Karaulov AB; Abronina IF
    Mol Biol (Mosk); 1979; 13(6):1287-95. PubMed ID: 161922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
    Suslov AP; Egorova SG; Brondz BD
    Biull Eksp Biol Med; 1975 Oct; 80(10):86-90. PubMed ID: 776251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological activity of regional lymph nodes in tumor-bearing mice.
    Barna BP; Deodhar SD
    Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of T-Suppressors concentrated by elution from an allogeneic cell monolayer].
    Abronina IF; Karaulov AV; Brondz BD
    Biull Eksp Biol Med; 1980 Feb; 89(2):202-5. PubMed ID: 6445215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.